Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene-Reference-Cited by-同舟云学术

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene

Published:2022-09 Issue: Volume:26 Page:532-546
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Viker Kimberly B.,Steele Michael B.,Iankov Ianko D.,Concilio Susanna C.,Ammayappan Arun,Bolon Brad,Jenks Nathan J.,Goetz Matthew P.,Panagioti Eleni,Federspiel Mark J.,Liu Minetta C.,Peng Kah Whye,Galanis Evanthia^ORCID

Funder

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference56 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Past, present, and future challenges in breast cancer treatment;Sledge;J. Clin. Oncol.,2014

3. HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors;Nielsen;Cancer Treat Rev.,2009

4. A phase ib trial of durvalumab in combination with trastuzumab in HER2-positive metastatic breast cancer (CCTG IND.229);Chia;Oncologist,2019

5. Efficacy and safety analysis of nelipepimut-S vaccine to prevent breast cancer recurrence: a randomized, multicenter, phase III clinical trial;Mittendorf;Clin. Cancer Res.,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions;Phytomedicine;2024-07

2. An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas;Current Treatment Options in Oncology;2024-06-19

3. Engineering Microorganisms for Cancer Immunotherapy;Advanced Healthcare Materials;2024-04-21

4. Oncolytic virus-based combination therapy in breast cancer;Cancer Letters;2024-03

5. Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity;mBio;2024-02-14